| APS | adenosine phosphosulfate; American Pain Society; American Pediatric Society; American Physiological ... |
|---|---|
| PAPS | 3'-phosphoadenosine-5'-phosphosulfate; primary antiphospholipid antibody syndrome |
| ST | esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor... |
| STP | phenol-preferring sulfotransferase; scientifically treated petroleum; sodium thiopental; standard te... |
| CAMP | Christie-Atkins-Munch-Petersen [test]; computer-assisted menu planning; concentration of adenosine m... |
| APS | Adenosine 5'-phosphosulfate |
|---|---|
| PAPS | 3'-Phosphoadenosine 5'-phosphosulfate |
| PAPS | 3'-phosphate 5'-phosphosulfate |
| ST | Sulfotransferase |
| AST | Aryl sulfotransferase |
| adenosine 5'-phosphosulfate sulfotransferase | <enzyme> Catalyses transfer of sulfo group of adenylylsulfate to a carrier organic thiol, forming carrier-bound thiosulfate and AMP Registry number: EC 2.8.2.- Synonym: apsstase, aps sulfotransferase, adenylylsulfate sulfotransferase (26 Jun 1999) |
|---|
| adenosine 3'-phosphate 5'-phosphosulfate | 3'-phosphoadenosine 5'-phosphosulfate;an intermediate in the formation of urinary ethereal sulfates, notable for containing a "high energy" sulfate bond; the 3'-OH of adenosine is replaced by -OPO3H2, the 5'-OH by -OP(O2H)-OSO3H. Synonym: active sulfate. Acronym: PAPS (05 Mar 2000) |
|---|---|
| adenosine 5'-phosphosulfate | An intermediate in the formation of PAPS (active sulfate). Adenosine 5'-phosphosulfate kinase, the enzyme that catalyses the formation of active sulfate from adenosine 5'-phosphosulfate and ATP. Acronym: APS (05 Mar 2000) |
| adenosine phosphosulfate | <chemical> 5'-adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonym: adenosine sulfatophosphate; aps. Chemical name: 5'-Adenylic acid, monoanhydride with sulfuric acid (12 Dec 1998) |
| phosphoadenosine phosphosulfate | <chemical> 3'-phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms. Chemical name: 3'-Adenylic acid, 5'-(dihydrogen phosphate), 5'-anhydride with sulfuric acid (12 Dec 1998) |
| 3'-phosphoadenosine 5'-phosphosulfate | 3'-phosphoadenosine 5'-phosphosulfate;an intermediate in the formation of urinary ethereal sulfates, notable for containing a "high energy" sulfate bond; the 3'-OH of adenosine is replaced by -OPO3H2, the 5'-OH by -OP(O2H)-OSO3H. Synonym: active sulfate. Acronym: PAPS (05 Mar 2000) |
| 3'-phosphoadenylyl-5'-phosphosulfate reductase | <enzyme> Used to detect thioredoxins from prokaryotic and eukaryotic organisms Registry number: EC 1.8.4.- Synonym: paps reductase (26 Jun 1999) |
| adenosine | <biochemistry> A ribonucleotide which consists of the nitrogenous base adenine linked to the sugar ribose. <drug> A cardiac drug used in terminating PSVT involving reentry pathways that include the AV node or Wolff-Parkinson-White syndrome. For atrial flutter, atrial fibrillation, atrial or ventricular tachycardias, adenosine may produce transient AV block that may help identify the rhythm. Pharmacologic action: Endogenous purine nucleoside that depresses AV node and sinus node activity. Brief duration of action (1-2 min). Dose: Rapid 6 mg IV bolus over 1-3 sec. May repeat at 12 mg IV bolus within 1-2 min Patients taking theophylline may require larger doses. Use a smaller dose with cardiac transplant patients. Potential complications: Common but transient - flushing, dyspnea, chest pain, bradycardia, and ventricular ectopy. Theophylline (and caffeine) blocks adenosine's effects. Dipyridamole potentiates adenosine's effects. Use other agents to avoid these drug interactions. (15 Mar 2000) |
| adenosine 3',5'-cyclic monophosphate | An activator of phosphorylase kinase and an effector of other enzymes, formed in muscle from ATP by adenylate cyclase and broken down to 5'-AMP by a phosphodiesterase; sometimes referred to as the "second messenger." A related compound (2',3') is also known. Synonym: cyclic adenylic acid, cyclic AMP, cyclic phosphate. Acronym: cAMP (05 Mar 2000) |
| adenosine 3',5'-cyclic phosphate phosphodiesterase | <enzyme> An enzyme that catalyses the hydrolysis of adenosine 3',5'-cyclic phosphate forming 5'-AMP. A crucial step in the regulation of cellular adenosine 3',5'-cyclic phosphate levels. Inhibited by caffeine. Synonym: cAMP phosphodiesterase. (05 Mar 2000) |
| adenosine 3'-phosphate | 3'-Adenylic acid. See: adenylic acid. (05 Mar 2000) |
| adenosine 5'-diphosphate | A condensation product of adenosine with pyrophosphoric acid, formed from ATP by the hydrolysis of the terminal phosphate group of the latter compound. Acronym: ADP (05 Mar 2000) |
| adenosine-5'-(n-ethylcarboxamide) | <chemical> A stable adenosine a1 and a2 receptor agonist. Experimentally, it inhibits camp and cgmp phosphodiesterase activity. Pharmacological action: antineoplastic agent, vasodilator agents. (12 Dec 1998) |
| adenosine 5'-phosphate | 5'-Adenylic acid. See: adenylic acid. (05 Mar 2000) |
| adenosine 5'-phosphoramidate hydrolase | <enzyme> Hydrolyzes nucleoside 5'-monophosphoramidates into nucleoside 5'-phosphates and ammonia Registry number: EC 3.9.1.- Synonym: ampn hydrolase, nucleoside monophosphoramidate hydrolase (26 Jun 1999) |
| adenosine 5'-triphosphate | Adenosinepyrophosphate;adenosine with triphosphoric acid esterfied at its 5' position; immediate precursors of adenine nucleotides in RNA. The primary energy currency of a cell. Synonym: adenosine triphosphate. Acronym: ATP (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|